Forecast & Rating2 analysts currently cover EKSO Bionics, of which 1 give a positive rating. The average price target is $9.50, about 19.5% downside from the current price of $11.80. Coverage is limited, so the data is for reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Dec 31, 2025Price forecast
$9.50-19.49%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateMay 4, 2026
Forecast met14.6%
Stock price$11.80
Avg. target$9.5
High target$10
Low target$10
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.